The donor template carries the DNA sequence researchers want cells to incorporate and provides guidance for repair after a targeted break. Cellular repair can use homology-directed repair, in which matching regions help position the incoming sequence, or related mechanisms. This connection between the break and donor template enables specific changes rather than an unspecified genomic alteration.
A defined genomic location links the inserted sequence to a particular gene or regulatory context. That precision allows researchers to examine how a mutation, reporter gene, epitope tag, or human disease variant affects gene function. It also supports interpretations based on the intended locus, rather than changes introduced at an unrelated site.
CRISPR-Cas systems provide the targeted DNA break that initiates the modification, while the cell’s repair machinery determines how the supplied donor sequence becomes incorporated. The two components therefore perform different but connected functions: one directs the editing event to a chosen genomic site, and the other uses the available repair pathway to complete the change.
A typical workflow selects a genomic site, uses a CRISPR-Cas system to create a targeted break, and supplies a donor template containing the desired sequence. Cellular repair then incorporates that sequence through homology-directed repair or a related mechanism. The resulting engineered cells or organisms can be examined for the intended change and its effect on gene function.
Researchers can use the method to introduce mutations, reporter genes, epitope tags, or human disease variants. These payloads serve different experimental purposes: mutations alter gene function, reporter genes help follow gene activity, epitope tags support investigation of a protein, and disease variants model medically relevant genetic changes in engineered systems.
The approach is useful when researchers need a defined genetic change to investigate gene regulation, protein localization, or disease mechanisms. Engineered cells and model organisms can carry reporters, tags, mutations, or disease variants, creating experimental systems that connect a specific DNA alteration with observable biological behavior and that can also inform studies of potential therapeutic strategies.